A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer
Clinical trial NCT02726009 · COMPLETED
Trial details
- NCT number
- NCT02726009
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2020-05-15
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.